These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 16166943
1. Rituximab in diffuse large B-cell lymphoma. Coiffier B. Clin Adv Hematol Oncol; 2004 Mar; 2(3):156-7. PubMed ID: 16166943 [No Abstract] [Full Text] [Related]
2. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma]. Wu HJ, Zhang QY, Chen DF, Guan XJ, Zhang BL, Ma J. Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800 [Abstract] [Full Text] [Related]
4. Fatal central nervous system lesions emerging during anti-CD20 monoclonal antibody therapy (Rituximab) for a post transplantation Epstein Barr virus-linked lymphoma. Sirvent-Von Bueltzingsloewen A, Sirvent N, Morand P, Cassuto JP. Med Pediatr Oncol; 2003 Jun; 40(6):408-9. PubMed ID: 12692818 [No Abstract] [Full Text] [Related]
15. A case of rituximab-related urticarial reaction in cutaneous B-cell lymphoma. Rey J, Wickenhauser S, Ivanov V, Coso D, Gastaut JA, Bouabdallah R. J Eur Acad Dermatol Venereol; 2009 Feb 01; 23(2):210. PubMed ID: 18482321 [No Abstract] [Full Text] [Related]
16. [Pure red cell aplasia successfully treated with rituximab in a patient with relapsed diffuse large B-cell lymphoma]. Suzuki T, Kumagai T, Kitano A, Kubo H, Tabata M, Kimura Y, Miura O, Imai Y. Rinsho Ketsueki; 2007 Jan 01; 48(1):67-70. PubMed ID: 17313080 [Abstract] [Full Text] [Related]